Ушбу иш иқтибос қилган ишлар

41 та иш

Иш: DISTRIBUTION OF POLYMORPHISMS OF GENES OF STATINS METABOLISM AND TRANSPORT IN THE LIVER IN PATIENTS WITH CORONARY ARTERY DISEASE ETHNIC UZBEKS WITH SIMVASTATIN INTOLERANCE

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

   Colin Baigent, Anthony Keech, Patricia M. Kearney +8

   Шарҳ мақола20056 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.244572

2. <i>SLCO1B1</i> Variants and Statin-Induced Myopathy — A Genomewide Study

   The SEARCH Collaborative Group

   Мақола20083 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.568856

3. Lipid-lowering response to statins is affected by CYP3A5 polymorphism

   Kari T. Kivistö, Mikko Niemi, Elke Schaeffeler +6

   Мақола20043 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.568866

4. Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects

   William E. Evans, Howard L. McLeod

   Мақола20033 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.568884

5. Effect of Polymorphic <i>CYP3A5</i> Genotype on the Single‐Dose Simvastatin Pharmacokinetics in Healthy Subjects

   Kyoung‐Ah Kim, Pil‐Whan Park, Ock‐Je Lee +2

   Мақола20063 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.568886

6. Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000

   Earl S. Ford, Umed A. Ajani, Janet B. Croft +5

   Мақола20072 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.244568

7. <i>CYP3AP1*3</i>Allele Is Associated With Lipid-Lowering Efficacy of Simvastatin and Atorvastatin in Chinese Women

   Yanpeng Li, Lirong Zhang, Min Jia +1

   Мақола20102 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.568862

8. The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment

   Marilu Fiegenbaum, F DASILVEIRA, C VANDERSAND +4

   Мақола20052 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.568864

9. CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort

   Joseph P. Kitzmiller, Jasmine A. Luzum, Damiano Baldassarre +2

   Мақола20142 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.568868

10. Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in The Rotterdam Study

    Laure Elens, Matthijs L. Becker, Vincent Haufroid +5

    Мақола20112 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.568870

11. CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity

    Fumihiro Sata

    Мақола20002 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.568871

12. Needed: Pragmatic Clinical Trials for Statin-Intolerant Patients

    Patricia D. Maningat, Jan L. Breslow

    Мақола20112 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.568874

13. Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

    Daqing Wang, Yingying Guo, Steven Wrighton +2

    Мақола20102 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.568875

14. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

    Marja K. Pasanen, Mikko Neuvonen, Pertti J. Neuvonen +1

    Мақола20062 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.568899

15. Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction

    Kristian Bailey, Simon P.R. Romaine, Beryl M. Jackson +12

    Мақола20102 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.697504

16. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

    Peter Kuehl, Jiong Zhang, Yvonne Lin +16

    Мақола20012 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.697510

17. ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

    Jenni E. Keskitalo, Oliver Zolk, Martin F. Fromm +3

    Мақола20092 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.697513

18. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.711827

19. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.711828

20. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.711829

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.711830

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.711831

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.711832

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.711833

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.711834